Therapeutic potential of cladribine in combination with STAT3 inhibitor against multiple myeloma

BACKGROUND: Cladribine or 2-chlorodeoxyadenosine (2-CDA) is a well-known purine nucleoside analog with particular activity against lymphoproliferative disorders, such as hairy cell leukemia (HCL). Its benefits in multiple myeloma (MM) remain unclear. Here we report the inhibitory effects of cladribi...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Jian, Wang, Shuiliang, Zhao, Ming, Deng, Xin-Sheng, Lee, Choon-Kee, Yu, Xiao-Dan, Liu, Bolin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141773/
https://www.ncbi.nlm.nih.gov/pubmed/21679466
http://dx.doi.org/10.1186/1471-2407-11-255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3141773/
https://www.ncbi.nlm.nih.gov/pubmed/21679466
http://dx.doi.org/10.1186/1471-2407-11-255

Ejemplares similares